- Research works
- 4 ▼ 8% vs 2018-21
- Citations
- 188 41.9 per fractional work
- Top-10% rate
- 8.7% all institutions 10.0%
- Open access
- 60% world 40%
- International
- 39% world 18%
Not ranked overall: Akston Biosciences (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Akston Biosciences (United States) work in?
In all years, 52% of research at Akston Biosciences (United States) is in Life Sciences, 39% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (41%), Medicine (37%), Agricultural and Biological Sciences (7%). It does 1.5× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 3 domains and 8 fields, with their numbers
- Life Sciences252.2%
- Health Sciences239.1%
- Medicine237.0%
- Veterinary02.2%
- Physical Sciences08.7%
- Engineering06.5%
- Environmental Science02.2%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Akston Biosciences (United States)?
Ranked on the quality score, Sylaja Murikipudi and Andrea R. Delpero lead among researchers whose main affiliation is Akston Biosciences (United States).
- 1
Sylaja Murikipudi
United States · #2,160,988 worldwide 659 citations · 16 works
- 2
Andrea R. Delpero
United States · #2,527,834 worldwide 260 citations · 21 works
Which research topics does Akston Biosciences (United States) publish most on?
By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, vaccines and immunoinformatics approaches, Growth Hormone and Insulin-like Growth Factors and Metabolism, Diabetes, and Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 2 vaccines and immunoinformatics approaches Molecular Biology 0 works
- 3 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 0 works
- 4 Metabolism, Diabetes, and Cancer Molecular Biology 0 works
- 5 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
- 6 COVID-19 Clinical Research Studies Infectious Diseases 0 works
- 7 T-cell and B-cell Immunology Immunology 0 works
- 8 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
- 9 Hyperglycemia and glycemic control in critically ill and hospitalized patients Endocrinology, Diabetes and Metabolism 0 works
- 10 Animal Virus Infections Studies Animal Science and Zoology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Akston Biosciences (United States)'s research output changed?
Output in 2022-2025 was 8% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Beverly
- Clinical Solutions
- Beverly Hospital
- Wound Healing Society
- School for Field Studies
- American Association for Thoracic Surgery
- Axcelis Technologies (United States)
- CCI Reprographics (United States)
- Rogers Sciences (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Akston Biosciences (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.